DNA Cell Cycle Analysis by Flow Cytometry
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
Cancer Antigen (CA) 19-9, Serum
Familial Adenomatous Polyposis (APC) Gene Mutation Analysis
Pseudocyst of pancreas
Cholangitis
Solid Tumor Gene Mutation Panel, NGS (Oncotype MAP™, Guardant360® CDx, Guardant Reveal™, PGDx elio™, Northstar Select®, oncoReveal™, LiquidHALLMARK®, PredicineATLAS™, PGDx elio™ Assay)
Epidermal Growth Factor Receptor (EGFR) Gene Mutation Analysis
MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
Acute myeloid leukemia (AML)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Cancer Antigen (CA) 19-9, Serum
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
Cancer Antigen (CA) 19-9, Serum
Medical Test
Overview
Access to
Cancer Antigen (CA) 19-9, Serum
is restricted.
Sign up now
Loading...